Karen Robinson to Disease Progression
This is a "connection" page, showing publications Karen Robinson has written about Disease Progression.
Connection Strength
0.053
-
Three-Month FVC Change: A Trial Endpoint for Idiopathic Pulmonary Fibrosis Based on Individual Participant Data Meta-analysis. Am J Respir Crit Care Med. 2022 04 15; 205(8):936-948.
Score: 0.038
-
Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care. 2009 Apr; 54(4):522-37.
Score: 0.015